Circulating MicroRNAs linked to type 2 diabetes

February 7, 2014
Circulating MicroRNAs linked to type 2 diabetes
Circulating microRNAs are associated with type 2 diabetes, and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

(HealthDay)—Circulating microRNAs (miRNAs) are associated with type 2 diabetes (T2D), and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

Francisco J. Ortega, Ph.D., from the Institut d'Investagació Biomédica de Girona in Spain, and colleagues assessed the circulating miRNA profile in 12 men: six with normal tolerance (NGT) and six with T2D. In an extended sample of 45 men with NGT and 48 with T2D, the association of 10 circulating miRNAs with T2D was validated cross-sectionally. Longitudinal validation was performed in 35 patients with T2D who were recruited in a randomized three-month metformin trial. In seven healthy volunteers, circulating miRNAs were also assessed before and after a six-hour hyperinsulinemic-euglycemic clamp and plus intralipid/heparin infusion.

In patients with T2D, the researchers identified increases in three miRNAs and decreases in seven miRNAs. After controlling for confounders, miR-140-5p and miR-423-5p independently accounted for 49.5 percent of fasting glucose variance. A discriminant function of four miRNAs (miR-140-5p, miR-423-5p, miR-195, and miR-126) was specific for T2D, with 89.2 percent accuracy. Significant changes in circulating miR-192, miR-140-5p, and miR-22 were seen with metformin but not placebo, in parallel to reduced fasting glucose and glycated hemoglobin. Decreased miR-222 was seen with insulin infusion during clamp, while increases in circulating miR-222 and miR-140-5p were seen with the intralipid/heparin mixture.

"This study depicts the close association between variations in circulating miRNAs and T2D and their potential relevance in ," the authors write.

The study was partially funded by an EFSD/Lilly Fellowship award.

Explore further: Atherosclerosis: Specific microRNAs promote inflammation

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Atherosclerosis: Specific microRNAs promote inflammation

March 22, 2013

(Medical Xpress)—Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet in Munich have now identified a microRNA that ...

Serum miR-21 putative biomarker for colorectal cancer

June 20, 2013

(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the National Cancer ...

Recommended for you

Electric fields weaker in slow-healing diabetic wounds

June 16, 2016

People with diabetes often suffer from wounds that are slow to heal and can lead to ulcers, gangrene and amputation. New research from an international group led by Min Zhao, professor of ophthalmology and of dermatology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.